[EXPERIENCE WITH A MYOTONOLYTIC (MYDOCALM) IN THE TREATMENT OF ARTERIAL OCCLUSIVE DISEASE OF THE EXTREMITIES].
D001162:Arteriosclerosis Obliterans; D004358:Drug Therapy; D004576:Electromyography; D005121:Extremities; D006429:Hemiplegia; D006801:Humans; D007383:Intermittent Claudication; D009125:Muscle Relaxants, Central; D009128:Muscle Spasticity; D009991:Oscillometry; D010243:Paralysis; D010276:Parasympatholytics; D011427:Propiophenones; D013924:Thrombophlebitis; D014049:Tolperisone
D009125:Muscle Relaxants, Central; D010276:Parasympatholytics; D011427:Propiophenones; D014049:Tolperisone
ARTERIOSCLEROSIS OBLITERANS; DRUG THERAPY; ELECTROMYOGRAPHY; HEMIPLEGIA; INTERMITTENT CLAUDICATION; MUSCLE RELAXANTS; OSCILLOMETRY; PARALYSIS, SPASTIC; PARASYMPATHOLYTICS; PROPIOPHENONES; THROMBOPHLEBITIS
ERFAHRUNGEN MIT MYOTONOLYTIKA (MYDOCALM) IN DER BEHANDLUNG ARTERIELLER VERSCHLUSSKRANKHEITEN IM GLIEDMASSENBEREICH.